1. Home
  2. APGE vs FHI Comparison

APGE vs FHI Comparison

Compare APGE & FHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$77.22

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Federated Hermes Inc.

FHI

Federated Hermes Inc.

HOLD

Current Price

$51.89

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
FHI
Founded
2022
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.0B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
APGE
FHI
Price
$77.22
$51.89
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$100.00
$49.00
AVG Volume (30 Days)
818.6K
609.6K
Earning Date
11-10-2025
01-29-2026
Dividend Yield
N/A
2.61%
EPS Growth
N/A
50.93
EPS
N/A
4.77
Revenue
N/A
$1,742,513,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
N/A
$6.95
P/E Ratio
N/A
$10.93
Revenue Growth
N/A
8.98
52 Week Low
$26.20
$35.05
52 Week High
$78.12
$54.42

Technical Indicators

Market Signals
Indicator
APGE
FHI
Relative Strength Index (RSI) 73.47 61.18
Support Level $74.48 $50.01
Resistance Level $76.87 $52.89
Average True Range (ATR) 3.37 0.96
MACD -0.06 0.29
Stochastic Oscillator 91.13 74.75

Price Performance

Historical Comparison
APGE
FHI

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About FHI Federated Hermes Inc.

Federated Hermes provides asset-management services for institutional and individual investors. The firm had $843.7 billion in managed assets at the end of June 2025, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (2%), and money market (75%) funds. The firm's cash-management operations are expected to generate around 52% of Federated's revenue this year, compared with 29%, 11%, and 8%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).

Share on Social Networks: